Search results for "Photosensitizing Agent"

showing 10 items of 67 documents

Triplet stabilization for enhanced drug photorelease from sunscreen-based photocages

2021

[EN] Recently, sunscreen-based drug photocages have been introduced to provide UV protection to photoactive drugs, thus increasing their photosafety. Here, combined experimental and theoretical studies performed on a photocage based on the commercial UVA filter avobenzone (AB) and on the photosensitizing non-steroidal anti-inflammatory drug ketoprofen (KP) are presented unveiling the photophysical processes responsible for the light-triggered release. Particular attention is paid to solvent stabilization of the drug and UV filter excited states, respectively, which leads to a switching between the triplet excited state energies of the AB and KP units. Most notably, we show that the stabiliz…

DrugUltraviolet Raysmedia_common.quotation_subjectUV filter010402 general chemistryPhotochemistry01 natural sciencesBiochemistrychemistry.chemical_compoundQUIMICA ORGANICAHexanesProdrugsPhysical and Theoretical Chemistrymedia_commonPropiophenonesQuenching (fluorescence)PhotolysisPhotosensitizing AgentsEthanol010405 organic chemistryOrganic ChemistryAnti-Inflammatory Agents Non-SteroidalAcceptor0104 chemical sciencesHexaneSolventchemistryModels ChemicalKetoprofenExcited stateSolventsAvobenzoneSunscreening AgentsOrganic and Biomolecular Chemistry
researchProduct

Swellable microparticles containing Suprofen: evaluation of in vitro release and photochemical behaviour

1998

Suprofen, an anti-inflammatory drug was incorporated in polymer networks based on biocompatible macromolecules, such as alpha,beta-polyasparthydrazide (PAHy) and alpha,beta-poly(N-hydroxyethyl)-DL-aspartamide (PHEA) crosslinked by glutaraldehyde or gamma-rays, respectively. Swelling tests carried out in aqueous media showed that pH value affects the swelling degree of the prepared hydrogels. In vitro release tests were performed in simulated gastrointestinal fluids (pH 1/6.8) using the pH variation method and in phosphate-buffered saline, pH 7.4. Experimental data indicated that Suprofen was released in a sustained way both from PAHy and PHEA microparticles. Further, incorporation of Suprof…

ErythrocytesPlasma SubstitutesSuprofenPharmaceutical ScienceSuprofenHemolysisDosage formchemistry.chemical_compoundmedicineHumansOrganic chemistryParticle SizeActive ingredientGastric JuicePhotosensitizing AgentsChromatographyAnti-Inflammatory Agents Non-SteroidalHydrogen-Ion ConcentrationNylonsCross-Linking ReagentsHydrazineschemistryGlutaralDelayed-Action PreparationsSelf-healing hydrogelsLiberationGlutaraldehydeSwellingmedicine.symptomPeptidesDrug carrierGelsmedicine.drugJournal of Controlled Release
researchProduct

A European multicentre photopatch test study

2012

The two most common agent groups currently responsible for photoallergic contact dermatitis (PACD) are organic ultraviolet (UV) absorbers in sunscreens and topical nonsteroidal anti-inflammatory drugs (NSAIDs). However, availability of information on the photoallergenic potential of these agents is scarce.To obtain current information on the frequency of PACD to 19 organic UV absorbers and five topical NSAIDs, including newer agents, in common usage in Europe.A prospective, multicentre photopatch test study was conducted with 1031 patients attending for investigation of suspected PACD in 30 centres across 12 European countries.A total of 346 PACD reactions in 200 (19·4%) subjects occurred. …

AdultMalemedicine.medical_specialtyAdolescentUltraviolet RaysPhotopatch testPhotoallergic Contact DermatitisSunscreening AgentsDermatologyYoung AdultmedicineHumansProspective StudiesYoung adultProspective cohort studyAgedAged 80 and overPhotosensitizing AgentsDermatitis Photoallergicbusiness.industryAnti-Inflammatory Agents Non-SteroidalPhotosensitizing AgentMiddle AgedPatch TestsDermatologySurgeryEuropePhotoallergensFemalebusinessSunscreening AgentsBritish Journal of Dermatology
researchProduct

Insight on pyrimido[5,4-g]indolizine and pyrimido[4,5-c]pyrrolo[1,2-a]azepine systems as promising photosensitizers on malignant cells

2022

Searching for new small molecules as photosensitizing agents, we have developed a class of twenty-five pyrimido[5,4-g]indolizine and pyrimido[4,5-c]pyrrolo[1,2-a]azepines with a good substitution pattern defining a versatile synthetic pathway to approach the title ring system. All compounds were evaluated for their photocytotoxicity on a triple negative human breast cancer cell line (MDA-MB-231) in the dark and under UVA light (2.0 J/cm2). The most effective compounds exhibited a photoantiproliferative activity with IC50 values up to nanomolar ranges. Interestingly, these new developed compounds showed high selectivity towards cancerous cells with respect to non-cancerous ones. Moreover, fo…

PharmacologyMDA-MB-231Triple negative human breast cancerOrganic ChemistryPhototoxic activityIndolizinesAntineoplastic AgentsApoptosisTriple Negative Breast Neoplasms4-g]indolizinespyrimido[4General MedicineAzepinespyrimido[54-g]indolizinespyrimido[45-c]pyrrolo[12-a]azepinesTriple negative human breast cancerMDA-MB-231Photosensitizing agentsPhototoxic activitypyrimido[5Photosensitizing agents5-c]pyrrolo[1pyrimido[45-c]pyrrolo[12-a]azepinesCell Line Tumor2-a]azepinesTriple negative human breast cancerMDA-MB-231Photosensitizing agentsPhototoxic activityDrug DiscoveryHumanspyrimido[54-g]indolizines
researchProduct

Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia

2005

Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) has proven to be safe and effective in patients with early neoplasia in Barrett's esophagus. However, long-term results in patients with high-grade intraepithelial neoplasia (HGIN) or with early cancer are still lacking.The aim of the study was to evaluate the efficacy of ALA-PDT and the survival of patients with early Barrett's neoplasia. ALA-PDT was carried out in 66 patients. Protoporphyrin IX induced by oral administration of ALA (60 mg/kg body weight orally applied 4-6 hours before PDT) was used as the photosensitizer. Acid suppression was maintained in all patients.Between September 1996 and September 2002, 667 patients with …

Malemedicine.medical_specialtyTime FactorsEsophageal Neoplasmsmedicine.medical_treatmentPhotodynamic therapyAdenocarcinomaSeverity of Illness IndexGastroenterologyDisease-Free SurvivalBarrett EsophagusGermanyInternal medicineHumansMedicineRadiology Nuclear Medicine and imagingEsophagusSurvival rateAgedNeoplasm StagingRetrospective StudiesIntraepithelial neoplasiaPhotosensitizing Agentsbusiness.industryGastroenterologyCancerAminolevulinic AcidMiddle Agedmedicine.diseaseSurvival RateTreatment Outcomemedicine.anatomical_structurePhotochemotherapyEsophagectomyHigh Grade Intraepithelial NeoplasiaAdenocarcinomaFemalebusinessPrecancerous ConditionsFollow-Up StudiesGastrointestinal Endoscopy
researchProduct

Synthesis, spectroscopic studies and biological evaluation of acridine derivatives: The role of aggregation on the photodynamic efficiency.

2018

Two new photoactive compounds (1 and 2) derived from the 9-amidoacridine chromophore have been synthesized and fully characterized. Their abilities to produce singlet oxygen upon irradiation have been compared. The synthesized compounds show very different self-aggregating properties since only 1 present a strong tendency to aggregate in water. Biological assays were conducted with two cell types: hepatoma cells (Hep3B) and human umbilical vein endothelial cells (HUVEC). Photodynamic therapy (PDT) studies carried out with Hep3B cells showed that non-aggregating compound 2 showed photoxicity, ascribed to the production of singlet oxygen, being aggregating compound 1 photochemically inactive.…

Cell typeCell SurvivalUltraviolet Raysmedicine.medical_treatmentClinical BiochemistryPharmaceutical SciencePhotodynamic therapy010402 general chemistry01 natural sciencesBiochemistrysinglet oxygenUmbilical veinchemistry.chemical_compoundStructure-Activity RelationshipCell Line TumorDrug DiscoverymedicineHuman Umbilical Vein Endothelial CellsBioassayHumansMolecular BiologyCell ProliferationPhotosensitizing AgentsDose-Response Relationship DrugMolecular Structure010405 organic chemistryChemistrySinglet oxygenOrganic ChemistryAcridine derivativesChromophore0104 chemical sciences9-Amidoacridinephotodynamic therapyMicroscopy FluorescencePhotochemotherapyCell cultureorganic nanoparticlesBiophysicsMolecular MedicineAcridinesself-aggregationBioorganicmedicinal chemistry letters
researchProduct

Cycloheptapyrrolo systems with antitumor properties

2013

Cycloheptapyrrolo systems photosensitizing agents antitumor agentsSettore CHIM/08 - Chimica Farmaceutica
researchProduct

Photochemical and Photobiological Studies of a Furonaphthopyranone as a Benzo-spaced Psoralen Analog in Cell-free and Cellular DNA

1997

Photobiological activities of the benzo-spaced psoralen analog furonaphthopyranone 3 have been investigated in cell-free and cellular DNA. The molecular geometry parameters of 3 suggest that it should not form interstrand crosslinks with DNA. With cell-free DNA no evidence for crosslinking but also not for monoadduct formation was obtained; rather, the unnatural furocoumarin 3 induces oxidative DNA modifications under near-UVA irradiation. The enzymatic assay of the photosensitized damage in cell-free PM2 DNA revealed the significant formation of lesions sensitive to formamidopyrimidine DNA glycosylase (Fpg protein). In the photooxidation of calf thymus DNA by the furonaphthopyranone 3, 0.2…

PhotochemistryUltraviolet RaysDNA damageMolecular ConformationCHO CellsPhotochemistryBiochemistryOxazolonechemistry.chemical_compoundCricetinaeFurocoumarinsAnimalsDeoxyguanosinePhysical and Theoretical ChemistryPsoralenPhotosensitizing AgentsCell-Free SystemMolecular StructureMutagenicity TestsFurocoumarinFicusinDeoxyguanosineDNAGeneral MedicineFormamidopyrimidine DNA glycosylaseComet assaychemistryDNA ViralMethoxsalenCattleDNADNA DamagePhotochemistry and Photobiology
researchProduct

Synthesis and In Vitro Evaluation of a Photosensitizer-BODIPY Derivative for Potential Photodynamic Therapy Applications

2015

A new photosensitizer (1) based on the 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) scaffold has been synthesized. 1 is water soluble and showed an intense absorption band at 490 nm (e=77600 cm-1M-1) and an emission at 514 nm. In vitro toxicity of 1 in the presence of light and in darkness has been studied with HeLa, HaCaT, MCF-7, and SCC-13 cell lines. Moreover, internalization studies of 1 in these cell lines were also performed. These results suggested that 1 is more toxic for SCC-13 and HeLa carcinoma cells than for the HaCaT noncancerous immortal human keratinocytes. Toxicity upon light irradiation was due to the formation of singlet oxygen and reactive oxygen species (ROS). Cel…

Boron CompoundsLightmedicine.medical_treatmentBodipyPhotodynamic therapyPhotochemistrysensorsBiochemistryHeLachemistry.chemical_compoundQUIMICA ORGANICACell Line TumormedicineBIOQUIMICA Y BIOLOGIA MOLECULARHumansPhotosensitizerchemistry.chemical_classificationReactive oxygen speciesPhotosensitizing AgentsphotochemistryMolecular StructureSinglet OxygenbiologySinglet oxygenEndoplasmic reticulumOrganic ChemistryQUIMICA INORGANICAGeneral Chemistrybiology.organism_classificationHaCaTPhotochemotherapychemistryphotodynamic therapyfluorescenceBODIPYReactive Oxygen Species
researchProduct

Synthesis and photocytotoxic activity of [1,2,3]triazolo[4,5-h][1,6]naphthyridines and [1,3]oxazolo[5,4-h][1,6]naphthyridines

2018

Abstract [1,2,3]Triazolo[4,5-h][1,6]naphthyridines and [1,3]oxazolo[5,4-h][1,6]naphthyridines were synthesized with the aim to investigate their photocytotoxic activity. Upon irradiation, oxazolo-naphtapyridines induced light-dependent cell death at nanomolar/low micromolar concentrations (EC50 0.01–6.59 μM). The most photocytotoxic derivative showed very high selectivity and photocytotoxicity indexes (SI = 72–86, PTI>5000), along with a triplet excited state with exceptionally long lifetime (18.0 μs) and high molar absorptivity (29781 ± 180 M−1cm−1 at λmax 315 nm). The light-induced production of ROS promptly induced an unquenchable apoptotic process selectively in tumor cells, with mitoch…

Pharmaceutical ScienceApoptosisMitochondrionPhotochemiotherapy; Photosensitizing agents; Reactive oxygen species; [123]Triazolo[45-h][16]naphthyridines; [13]oxazolo[54-h][16]naphthyridines; Pharmacology; Drug Discovery; Pharmaceutical Science; Organic Chemistry01 natural sciencesMedicinal chemistry[13]oxazolo[54-h][16]naphthyridinechemistry.chemical_compoundDrug Discovery6]naphthyridineschemistry.chemical_classification0303 health sciencesTumorPhotosensitizing AgentsCell DeathSinglet OxygenSinglet oxygenPhotochemiotherapy; Photosensitizing agents; Reactive oxygen species; [1; 2; 3]Triazolo[4; 5-h][1; 6]naphthyridines; [1; 3]oxazolo[5; 4-h][1; 6]naphthyridines; Apoptosis; Cell Death; Cell Line; Tumor; Humans; Lysosomes; Mitochondria; Naphthyridines; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Singlet OxygenGeneral MedicineLysosomeMitochondriaExcited stateReactive oxygen specie5-h][1HumanProgrammed cell death2NaphthyridinePhotochemiotherapy3]Triazolo[4Cell Line03 medical and health sciences4-h][1Cell Line TumorHumansNaphthyridines030304 developmental biologyPharmacologyReactive oxygen speciesPhotosensitizing agent010405 organic chemistryOrganic ChemistryApoptosi0104 chemical sciences3]oxazolo[5chemistryPhotochemotherapyCell cultureApoptosis[123]Triazolo[45-h][16]naphthyridine[1LysosomesReactive Oxygen SpeciesDerivative (chemistry)
researchProduct